GENE Momentum building - a year in review
30. August 2022 08:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in guideline driven genomics-based tests in health,...
Gene achieves key milestones and growth
28. Juli 2022 08:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, July 28, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and...
GeneType launches Multi-Test in Obstetrics clinics with more than 1,000 referring primary care physicians
18. Juli 2022 08:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, July 18, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and...
Completion of AffinityDNA Acquisition expanding global direct-to-consumer business
14. Juli 2022 08:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, July 14, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and...
EasyDNA expands Indian and European markets; launching NIPT, Carrier testing and DNA storage
05. Juli 2022 08:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, July 05, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and...
GeneType Risk Assessment Test onboarding in 16 clinics
01. Juli 2022 08:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, July 01, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and...
Transformational Pathway to US Payer System; Attributing US$1.4 Billion Health and Economic Benefit from geneType Breast Cancer Risk Assessment Test
16. Juni 2022 08:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, June 16, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and...
Acquisition of global direct to consumer ecommerce business
16. Mai 2022 09:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, May 16, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and...
Genetic Technologies drives leadership in precision medicine with Multi-Risk Test
08. April 2022 08:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, April 08, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ: GENE, ASX: GTG) (“GENE” or the “Company”), a global leader in genomics-based tests in health, wellness...
US Patent Office Grants Patent for COVID-19 Risk Test
23. Februar 2022 08:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and...